According to a previous study, IDO1 expression could serve as a favorable prognostic biomarker in undifferentiated pleomorphic sarcoma (UPS), which is consistent with our results (Ishihara et al., 2021). Here, IDO1 is linked to undifferentiated pleomorphic sarcoma.